アジ・バイオファーマのプレスリリース プレスリリース 2020年6月30日 味の素バイオファーマサービス、医薬品製造向け「AJILITY Fast Track」プラットフォームを発表 詳細を見る June 2, 2020 Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India 詳細を見る May 27, 2020 Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19 詳細を見る May 5, 2020 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials 詳細を見る April 30, 2020 Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic 詳細を見る March 10, 2020 Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board 詳細を見る September 2, 2019 Information accompanying the revision of the consumption tax rate 詳細を見る August 29, 2019 Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India 詳細を見る April 9, 2019 Information on Service Brand Name Change 詳細を見る April 9, 2019 GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center 詳細を見る April 3, 2019 Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing 詳細を見る March 12, 2019 Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth 詳細を見る 読み込み中…さらに読み込む
